AstraZeneca (Finland)

Recent papers from AstraZeneca (Finland)

1. Baxdrostat/Dapagliflozin vs. Placebo/Dapagliflozin in Adults with CKD with Hypertension: BaxDuo-Arctic Phase 3 Study Design and Baseline CharacteristicsJournal of the American Society of Nephrology · 2026
2. Irreversible myeloperoxidase inhibitor mitiperstat and mitiperstat metabolites display immunogenicity in humansToxicological Sciences · 2026
3. Baseline characteristics and antihypertensive patterns in Finnish patients with hypertension and kidney diseaseEuropean Heart Journal · 2026
4. Long-term cost-effectiveness of CKD screening in middle-aged adultsNephrology Dialysis Transplantation · 2026
5. Absorption, distribution, metabolism and excretion of londamocitinib after single‐dose inhaled, intravenous and oral administration in healthy participantsBritish Journal of Clinical Pharmacology · 2026
6. Rapid Alternating Polarity‐Enabled Electrochemical Decarboxylative Borylation of Aryl Carboxylic AcidsChemElectroChem · 2026
7. Protocol for the Therapy Personalisation Using Multiomic Analyses in Inflammatory Bowel Disease (THAMES‐IBD) StudyJCC Plus · 2026
8. The Future of all‐Comers Trials in the Era of Precision OncologyClinical Pharmacology & Therapeutics · 2026
9. Nonclinical Development of Oligonucleotide-Based Therapeutics: Insights from an IQ DruSafe ONT Working Group SurveyNucleic Acid Therapeutics · 2026
10. High Conservation of the Human Metapneumovirus Fusion Protein in Contemporary Global Sequences Supports Its Continued Relevance for Therapeutic and Prophylactic ConsiderationMicroorganisms · 2026
11. Population Pharmacokinetics and Exposure–response Analysis of Durvalumab in Patients with Limited-stage Small-cell Lung Cancer in the Phase 3 ADRIATIC StudyThe AAPS Journal · 2026
12. PGE2 Enhances Human ILC3 Function but Constrains ILC2‐to‐ILC3 PlasticityEuropean Journal of Immunology · 2026
13. Incorporation of a pH-Sensitive Linker into Lipid–ASO Conjugates Drives Increased Endosomal Membrane Remodeling EventsNucleic Acid Therapeutics · 2026
14. Discovery of Epidermal Growth Factor‐Like 7 as a Potential Non‐Invasive Biomarker for Fibrosis and Mortality Risk in MASLDClinical and Translational Science · 2026
15. Initial Changes in eGFR during Treatment with Balcinrenone and DapagliflozinClinical Journal of the American Society of Nephrology · 2026
16. Next‐Generation Manufacturing: The Evolving Role of Biocatalysis in AstraZenecaChemBioChem · 2026
17. RBProximity-CLIP enables subcellular mapping of RNA-binding protein interactions at nucleotide resolutionGenome biology · 2026
18. Antihypertensive Medication Patterns in Patients with Hypertension that is Harder to Control: Insights from the EnligHTN StudyAdvances in Therapy · 2026
19. Non‐contrast CT Markers of Hematoma Expansion and Andexanet Response in Factor Xa Inhibitor‐Associated Intracerebral Hemorrhage: An Analysis from ANNEXa ‐I TrialAnnals of Neurology · 2026
20. Tozorakimab to Prevent COPD ExacerbationsNew England Journal of Medicine · 2026